Drug General Information
Drug ID
D0R5HK
Former ID
DNC001353
Drug Name
Sodium valproate
Drug Type
Small molecular drug
Indication Discovery agent Investigative [537744]
Structure
Download
2D MOL

3D MOL

Formula
C8H15NaO2
Canonical SMILES
CCCC(CCC)C(=O)[O-].[Na+]
InChI
1S/C8H16O2.Na/c1-3-5-7(6-4-2)8(9)10;/h7H,3-6H2,1-2H3,(H,9,10);/q;+1/p-1
InChIKey
AEQFSUDEHCCHBT-UHFFFAOYSA-M
CAS Number
CAS 1069-66-5
PubChem Compound ID
PubChem Substance ID
ChEBI ID
ChEBI:9925
SuperDrug ATC ID
N03AG01
SuperDrug CAS ID
cas=000099661
Target and Pathway
Target(s) 4-aminobutyrate aminotransferase, mitochondrial Target Info Inhibitor [537744]
BioCyc Pathway GABA shunt
Valine degradation
Beta-alanine degradation
4-aminobutyrate degradation
KEGG Pathway Alanine, aspartate and glutamate metabolism
Valine, leucine and isoleucine degradation
beta-Alanine metabolism
Propanoate metabolism
Butanoate metabolism
Metabolic pathways
GABAergic synapse
PANTHER Pathway Aminobutyrate degradation
Pyrimidine Metabolism
Gamma-aminobutyric acid synthesis
PathWhiz Pathway Aspartate Metabolism
Glutamate Metabolism
Beta-Alanine Metabolism
Valine, Leucine and Isoleucine Degradation
Propanoate Metabolism
WikiPathways GABA synthesis, release, reuptake and degradation
Alanine and aspartate metabolism
References
Ref 537744Influence of a GABA transaminase inhibitor on central nervous system oxygen toxicity. Aviat Space Environ Med. 1978 Jul;49(7):877-9.
Ref 537744Influence of a GABA transaminase inhibitor on central nervous system oxygen toxicity. Aviat Space Environ Med. 1978 Jul;49(7):877-9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.